Skip to main content
AVXL logo

AVXL · Anavex Life Sciences Corp.

Track AVXL — free
$2.86 +0.01 (+0.35%) At close · Sep 4
Market Cap
$265.11M
Shares
92.70M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Coverage backlog: 47 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.
Key facts CIK 1314052 CUSIP 032797300 13F (30d) 135 filings 135 filers Visit website